These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8756699)

  • 1. Identification of an epitope in antithrombin appearing on insertion of the reactive-bond loop into the A beta-sheet.
    Nordling K; Björk I
    Biochemistry; 1996 Aug; 35(32):10436-40. PubMed ID: 8756699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
    Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
    Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic evidence for insertion of the reactive-bond loop of antithrombin into the A beta-sheet of the inhibitor during trapping of target proteinases.
    Björk I; Nordling K; Olson ST
    Biochemistry; 1993 Jul; 32(26):6501-5. PubMed ID: 7687144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a functional epitope in plasminogen activator inhibitor-1, not localized in the reactive center loop.
    Debrock S; Declerck PJ
    Thromb Haemost; 1998 Mar; 79(3):597-601. PubMed ID: 9531048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through hinge region mutations.
    Huntington JA; Fan B; Karlsson KE; Deinum J; Lawrence DA; Gettins PG
    Biochemistry; 1997 May; 36(18):5432-40. PubMed ID: 9154925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrophobic residues 382-386 of antithrombin III, Ala-Ala-Ala-Ser-Thr, serve as the epitope for an antibody which facilitates hydrolysis of the inhibitor by thrombin.
    Asakura S; Hirata H; Okazaki H; Hashimoto-Gotoh T; Matsuda M
    J Biol Chem; 1990 Mar; 265(9):5135-8. PubMed ID: 1690736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The intact and cleaved human antithrombin III complex as a model for serpin-proteinase interactions.
    Schreuder HA; de Boer B; Dijkema R; Mulders J; Theunissen HJ; Grootenhuis PD; Hol WG
    Nat Struct Biol; 1994 Jan; 1(1):48-54. PubMed ID: 7656006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R; Sobel M; McAdory LE; Harris RB
    Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of heparin activation of antithrombin. Evidence for reactive center loop preinsertion with expulsion upon heparin binding.
    Huntington JA; Olson ST; Fan B; Gettins PG
    Biochemistry; 1996 Jul; 35(26):8495-503. PubMed ID: 8679610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B; Brieditis I; Bock SC; Olson ST; Björk I
    Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion of antithrombin from an inhibitor of thrombin to a substrate with reduced heparin affinity and enhanced conformational stability by binding of a tetradecapeptide corresponding to the P1 to P14 region of the putative reactive bond loop of the inhibitor.
    Björk I; Ylinenjärvi K; Olson ST; Bock PE
    J Biol Chem; 1992 Jan; 267(3):1976-82. PubMed ID: 1730729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cleaved and latent forms of antithrombin are normal constituents of blood plasma: a quantitative method to measure cleaved antithrombin.
    Kjellberg M; Ikonomou T; Stenflo J
    J Thromb Haemost; 2006 Jan; 4(1):168-76. PubMed ID: 16409466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2.6 A structure of antithrombin indicates a conformational change at the heparin binding site.
    Skinner R; Abrahams JP; Whisstock JC; Lesk AM; Carrell RW; Wardell MR
    J Mol Biol; 1997 Feb; 266(3):601-9. PubMed ID: 9067613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two conformational states of Turkey ovomucoid third domain at low pH: three-dimensional structures, internal dynamics, and interconversion kinetics and thermodynamics.
    Song J; Laskowski M; Qasim MA; Markley JL
    Biochemistry; 2003 Jun; 42(21):6380-91. PubMed ID: 12767219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of sequential oligopeptide carriers on the bioactive structure of conjugated epitopes: comparative study of the conformation of a Herpes simplex virus glycoprotein gD-1 epitope in the free and conjugated form, and protein "built-in" crystal structure.
    Krikorian D; Stavrakoudis A; Biris N; Sakarellos C; Andreu D; de Oliveira E; Mezö G; Majer Z; Hudecz F; Welling-Wester S; Cung MT; Tsikaris V
    Biopolymers; 2006; 84(4):383-99. PubMed ID: 16493659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing serpin reactive-loop conformations by proteolytic cleavage.
    Chang WS; Wardell MR; Lomas DA; Carrell RW
    Biochem J; 1996 Mar; 314 ( Pt 2)(Pt 2):647-53. PubMed ID: 8670081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a monoclonal antibody, D73H, that maps to a highly conserved region on fibrinogen Bbeta chain.
    Rybarczyk BJ; Pereira M; Simpson-Haidaris PJ
    Thromb Haemost; 2000 Jul; 84(1):43-8. PubMed ID: 10928468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.